ASTRO Annual Meeting

The latest news out of ASTRO Annual Meeting, including researcher interviews and physician perspective.

Meeting News CoveragePerspective

Eltrombopag increases rate of hematologic response in severe aplastic anemia

December 21, 2015
ORLANDO, Fla. — The addition of eltrombopag to immunosuppressive treatment increased complete hematologic response rates in patients with…
Meeting News Coverage

Idelalisib combination reduces risk for progression, death in refractory CLL

December 18, 2015
ORLANDO, Fla. — The addition of idelalisib to bendamustine and rituximab prolonged PFS and OS among patients with relapsed/refractory chronic…
In the JournalsPerspective

Brentuximab vedotin combinations yield encouraging response rates in elderly Hodgkin’s lymphoma

December 18, 2015
ORLANDO, Fla. — Brentuximab vedotin conferred 100% objective response rates when combined with dacarbazine or bendamustine for the first-line…
Meeting News CoveragePerspective

Early PET scans guide de-escalation of therapy for advanced Hodgkin’s lymphoma

December 17, 2015
ORLANDO, Fla. — PET scans performed following two cycles of the chemotherapeutic regimen BEACOPP can be safely used to guide subsequent…
Meeting News CoveragePerspective

Depression prior to HSCT linked to increased mortality, GVHD risk

December 17, 2015
ORLANDO, Fla. — A depression diagnosis prior to allogeneic hematopoietic stem cell transplantation appeared associated with a greater risk for…
Meeting News CoveragePerspective

Ibrutinib extends PFS in relapsed, refractory mantle cell lymphoma

December 17, 2015
ORLANDO, Fla. — Treatment with ibrutinib prolonged PFS and led to a significantly higher overall response rate compared with temsirolimus in…
Meeting News CoveragePerspective

Matched-sibling HSCT often successful for patients with sickle cell disease

December 16, 2015
ORLANDO, Fla. — Hematopoietic stem cell transplantation from human leukocyte antigen-matched siblings was successful among more than 90% of…
Meeting News CoveragePerspective

Ibrutinib, rituximab appear safe, effective for treatment-naive follicular lymphoma

December 16, 2015
ORLANDO, Fla. — Combined treatment with ibrutinib and rituximab demonstrated robust clinical activity and produced a high overall response rate…
Meeting News CoveragePerspective

Eltrombopag improves platelet counts, reduces fatigue for some patients with severe thrombocytopenia

December 16, 2015
ORLANDO, Fla. — Eltrombopag improved platelet counts and alleviated fatigue among low-risk patients with myelodysplastic syndromes who…
Meeting News Coverage

Higher-volume facilities associated with improved survival for NHL

December 8, 2015
ORLANDO, Fla. — Patients with non-Hodgkin’s lymphoma who are treated at facilities with a high volume of similar patients experienced…